Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oman TeleStroke Initiative
NCT07721129Phase 4Not yet recruiting
- Sponsor
- Oman Ministry of Health
- Start
- Aug 2026
- Primary completion
- Dec 2026
01
Overview
A Phase 4 trial of tissue-plasminogen activator, tenecteplase in ischemic stroke, sponsored by Oman Ministry of Health. Planned start Aug 2026; status: not yet recruiting.
02
Drugs
tissue-plasminogen activatortenecteplase
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT07721129.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07721129.